HMGB1 induces hepcidin upregulation in astrocytes and causes an acute iron surge and subsequent ferroptosis in the postischemic brain
2
조회
0
다운로드
1
인용
0
참고문헌
초록
Dysregulation of brain iron levels causes functional disturbances and damages neurons. Hepcidin (a peptide hormone) plays a principal role in regulating intracellular iron levels by modulating ferroportin (FPN, the only known iron exporter) through triggering its internalization and lysosomal degradation. We observed a significant and rapid iron surge in the cortices of ischemic hemispheres at 3 h after cerebral ischemia (middle cerebral artery occlusion, MCAO) that was maintained until 4 d post-MCAO. We showed upregulation of hepcidin expression in the brain as early as 3 h post-MCAO, mainly in astrocytes, and significant hepcidin accumulation in serum from 6 h post-MCAO, and these inductions were maintained for 1 day and 7 days, respectively. High mobility group box 1 (HMGB1), a prototypic danger-associated molecular pattern, accumulates markedly after transient MCAO and plays critical roles in damage aggravation via its proinflammatory effects. Here, we demonstrated that treatment with recombinant HMGB1 stimulated astrocytes to induce hepcidin expression in a TLR4- and CXCR4-dependent manner. Furthermore, hepcidin-mediated intracellular iron accumulation in neurons was confirmed by an experiment using N-methyl-D-aspartate (NMDA)-conditioned medium-treated primary astrocytes and fresh primary cortical neurons treated with hepcidin-containing astrocyte-conditioned medium. Moreover, HMGB1-mediated local hepcidin upregulation and subsequent local iron surge were found to cause ferroptosis in the postischemic brain, which was suppressed by the functional blocking of HMGB1 using intranasally administered HMGB1 A box or anti-HMGB1 antibody. These findings show that HMGB1 serves as a ferroptosis inducer by upregulating hepcidin in astrocytes and thus aggravates acute damage in the postischemic brain.
Abstract
Dysregulation of brain iron levels causes functional disturbances and damages neurons. Hepcidin (a peptide hormone) plays a principal role in regulating intracellular iron levels by modulating ferroportin (FPN, the only known iron exporter) through triggering its internalization and lysosomal degradation. We observed a significant and rapid iron surge in the cortices of ischemic hemispheres at 3 h after cerebral ischemia (middle cerebral artery occlusion, MCAO) that was maintained until 4 d post-MCAO. We showed upregulation of hepcidin expression in the brain as early as 3 h post-MCAO, mainly in astrocytes, and significant hepcidin accumulation in serum from 6 h post-MCAO, and these inductions were maintained for 1 day and 7 days, respectively. High mobility group box 1 (HMGB1), a prototypic danger-associated molecular pattern, accumulates markedly after transient MCAO and plays critical roles in damage aggravation via its proinflammatory effects. Here, we demonstrated that treatment with recombinant HMGB1 stimulated astrocytes to induce hepcidin expression in a TLR4- and CXCR4-dependent manner. Furthermore, hepcidin-mediated intracellular iron accumulation in neurons was confirmed by an experiment using N-methyl-D-aspartate (NMDA)-conditioned medium-treated primary astrocytes and fresh primary cortical neurons treated with hepcidin-containing astrocyte-conditioned medium. Moreover, HMGB1-mediated local hepcidin upregulation and subsequent local iron surge were found to cause ferroptosis in the postischemic brain, which was suppressed by the functional blocking of HMGB1 using intranasally administered HMGB1 A box or anti-HMGB1 antibody. These findings show that HMGB1 serves as a ferroptosis inducer by upregulating hepcidin in astrocytes and thus aggravates acute damage in the postischemic brain.
참고문헌 (60)
- Singh, N. S., "Brain iron homeostasis : from molecular mechanisms to clinical significance and therapeutic opportunities", Antioxid. Redox Signal, 20, pp.1324~1363 (2014)
- Urrutia, P. J., "Inflaming the brain with iron", Antioxidants, 10, pp.61~ (2021)
- DeGregorio-Rocasolano, N., "Deciphering the iron side of stroke : neurodegeneration at the crossroads between iron dyshomeostasis, excitotoxicity, and ferroptosis", Front. Neurosci, 13, pp.85~ (2019)
- Raven, E. P., "Increased iron levels and decreased tissue integrity in hippocampus of Alzheimer’s disease detected in vivo with magnetic resonance imaging", J. Alzheimers. Dis, 37, pp.127~136 (2013)
- Greenough, M. A., "Metal dyshomeostasis and oxidative stress in Alzheimer’s disease", Neurochem. Int, 62, pp.540~555 (2013)
- Dietrich, R. B., "Iron accumulation in the basal ganglia following severe ischemic-anoxic insults in children", Radiology, 168, pp.203~206 (1988)
- Hare, D. J., "An iron-dopamine index predicts risk of parkinsonian neurodegeneration in the substantia nigra pars compacta", Chem. Sci, 5, pp.2160~2169 (2014)
- Skouta, R., "Ferrostatins inhibit oxidative lipid damage and cell death in diverse disease models", J. Am. Chem. Soc, 136, pp.4551~4556 (2014)
- Tuo, Q. Z., "Tau-mediated iron export prevents ferroptotic damage after ischemic stroke", Mol. Psychiatr, 22, pp.1520~1530 (2017)
- Ding, H., "Hepcidin is involved in iron regulation in the ischemic brain", Plos One, 6, pp.e25324~ (2011)
- DeGregorio-Rocasolano, N., "Iron-loaded transferrin(Tf)is detrimental whereas iron-free Tf confers protection against brain ischemia by modifying blood Tf saturation and subsequent neuronal damage", Redox Biol, 15, pp.143~158 (2018)
- Slomka, A., "Hepcidin levels are increased in patients with acute ischemic stroke : preliminary report", J. Stroke Cerebrovasc, 24, pp.1570~1576 (2015)
- Petrova, J., "Ischemic stroke, inflammation, iron overload - connection to a hepcidin", Int. J. Stroke, 11, pp.Np16~Np17 (2016)
- Millerot-Serrurot, E., "Temporal changes in free iron levels after brain ischemia-Relevance to the timing of iron chelation therapy in stroke", Neurochem. Int, 52, pp.1442~1448 (2008)
- Garcia-Yebenes, I., "Iron overload, measured as serum ferritin, increases brain damage induced by focal ischemia and early reperfusion", Neurochem. Int, 61, pp.1364~1369 (2012)
- Nemeth, E., "Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization", Science, 306, pp.2090~2093 (2004)
- Meynard, D., "The liver: conductor of systemic iron balance", Blood, 123, pp.168~176 (2014)
- Gnana-Prakasam, J. P., "Hepcidin expression in mouse retina and its regulation via lipopolysaccharide", Toll-like receptor-4 pathway independent of Hfe, 2008, pp.411, 79~88
- Simonis, G., "The iron-regulatory peptide hepcidin is upregulated in the ischemic and in the remote myocardium after myocardial infarction", Eur. Heart J, 31, pp.44~45 (2010)
- Kulaksiz, H., "The iron-regulatory peptide hormone hepcidin : expression and cellular localization in the mammalian kidney", J. Endocrinol, 184, pp.361~370 (2005)
- Raha-Chowdhury R., "Expression and cellular localization of hepcidin mRNA and protein in normal rat brain", BMC Neurosci, 16 (2015)[DOI]
- Wang, S. M., "Role of hepcidin in murine brain iron metabolism", Cell Mol. Life Sci, 67, pp.123~133 (2010)
- Xiong, X. Y., "Serum hepcidin concentrations correlate with serum iron level and outcome in patients with intracerebral hemorrhage", Neurol. Sci, 36, pp.1843~1849 (2015)
- Azab, S. F., "Serum hepcidin levels in childhood-onset ischemic stroke a case-control study", Medicine, 95, pp.e2921~ (2016)
- Xiong, X. Y., "Toll-like receptor 4", MyD88-mediated signaling of hepcidin expression causing brain iron accumulation, oxidative injury, and cognitive impairment after intracerebral hemorrhage, 2016, pp.134, 1025~1038
- Raha, A. A., "The systemic iron-regulatory proteins hepcidin and ferroportin are reduced in the brain in Alzheimer’s disease", Acta Neuropathol. Com, 1 (2013)[DOI]
- Sternberg, Z., "Serum hepcidin levels, iron dyshomeostasis and cognitive loss in Alzheimer’s disease", Aging Dis, 8, pp.215~227 (2017)
- Xu, Q., "Hepcidin plays a key role in 6-OHDA induced iron overload and apoptotic cell death in a cell culture model of Parkinson’s disease", Parkinsons Dis (2016)[DOI]
- Chen, D., "EGCG protects against 6-OHDA-induced neurotoxicity in a cell culture model", Parkinsons Dis (2015)[DOI]
- Ellidag, H. Y., "Serum iron metabolism markers including hepcidin in multiple sclerosis patients", Neurochem. J, 8, pp.226~230 (2014)
- Hanninen, M. M., "Expression of iron-related genes in human brain and brain tumors", BMC Neurosci, 10, pp.36~ (2009)
- Iadecola, C., "The immunology of stroke : from mechanisms to translation", Nat. Med, 17, pp.796~808 (2011)
- Urrutia, P., "Inflammation alters the expression of DMT1, FPN1 and hepcidin, and it causes iron accumulation in central nervous system cells", J. Neurochem, 126, pp.541~549 (2013)
- Ma, J., "Different characteristics of hepcidin expression in IL-6+", + and IL-6-, Neurochem. Res, pp.2018, 43[DOI]
- You, L. H., "Astrocyte hepcidin is a key factor in LPS-induced neuronal apoptosis", Cell Death Dis, 8, pp.e2676~ (2017)
- Kim, J. B., "HMGB1, a novel cytokine-like mediator linking acute neuronal death and delayed neuroinflammation in the postischemic brain", J. Neurosci, 26, pp.6413~6421 (2006)
- Kim, S. W., "Glycyrrhizic acid affords robust neuroprotection in the postischemic brain via anti-inflammatory effect by inhibiting HMGB1 phosphorylation and secretion", Neurobiol. Dis, 46, pp.147~156 (2012)
- Shin, J. H., "Ethyl pyruvate inhibits HMGB1 phosphorylation and secretion in activated microglia and in the postischemic brain", Neurosci. Lett, 558, pp.159~163 (2014)
- Venereau, E., "Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release", J. Exp. Med, 209, pp.1519~1528 (2012)
- Yang, H., "High mobility group box protein 1(HMGB1) : the prototypical endogenous danger molecule", Mol. Med, 21, pp.S6~S12 (2015)
- Kim, I. D., "Alarmin HMGB1 induces systemic and brain inflammatory exacerbation in post-stroke infection rat model", Cell Death Dis, 9, pp.426~ (2018)
- 이용수, "Hepatocyte toll-like receptor 4 mediates lipopolysaccharide-induced hepcidin expression", Experimental and Molecular Medicine, 49, pp.1~9 (2017), 생화학분자생물학회
- Jin, Y., "Biodegradable gelatin microspheres enhance the neuroprotective potency of osteopontin via quick and sustained release in the post-ischemic brain", Acta Biomater, 10, pp.3126~3135 (2014)
- Shin, J. H., "Ethyl pyruvate-mediated Nrf2 activation and hemeoxygenase 1 induction in astrocytes confer protective effects via autocrine and paracrine mechanisms", Neurochem. Int, 61, pp.89~99 (2012)
- Li, Q., "Inhibition of neuronal ferroptosis protects hemorrhagic brain", JCI Insight, 2, pp.e90777~ (2017)
- Wang, P. N., "Mitochondrial ferritin attenuates cerebral ischaemia", reperfusion injury by inhibiting ferroptosis, 2021, pp.12, 447~
- Ge, H. F., "Ferrostatin-1 alleviates white matter injury via decreasing ferroptosis following spinal cord injury", Mol. Neurobiol, 59, pp.161~176 (2022)
- Rouault, T. A., "Brain iron metabolism", Semin. Pediatr. Neurol, 13, pp.142~148 (2006)
- van Breda, G. F., "Cardiac hepcidin expression associates with injury independent of iron", Am. J. Nephrol, 44, pp.368~378 (2016)
- van Swelm, R. P., "Renal handling of circulating and renal-synthesized hepcidin and its protective effects against hemoglobin-mediated kidney injury", J. Am. Soc. Nephrol, 27, pp.2720~2732 (2016)
- Guida, C., "A novel inflammatory pathway mediating rapid hepcidin-independent hypoferremia", Blood, 125, pp.2265~2275 (2015)
- Zhang F. L., "Impairment of hepcidin upregulation by lipopolysaccharide in the interleukin-6 knockout mouse brain", Front. Mol. Neurosci, 10 (2017)[DOI]
- Moos, T., "Ferroportin in the postnatal rat brain : implications for axonal transport and neuronal export of iron", Semin. Pediatr. Neurol, 13, pp.149~157 (2006)
- Zarruk, J. G., "Expression of iron homeostasis proteins in the spinal cord in experimental autoimmune encephalomyelitis and their implications for iron accumulation", Neurobiol. Dis, 81, pp.93~107 (2015)
- Shin, J. A., "Iron released from reactive microglia by noggin improves myelin repair in the ischemic brain", Neuropharmacology, 133, pp.202~215 (2018)
- Healy, S., "Significant glial alterations in response to iron loading in a novel organotypic hippocampal slice culture model", Sci. Rep, 6, pp.36410~ (2016)
- Pelizzoni, I., "Iron uptake in quiescent and inflammation-activated astrocytes : a potentially neuroprotective control of iron burden", Biochim. Biophys. Acta, 1832, pp.1326~1333 (2013)
- Ye, F. H., "HMGB1 regulates erastin-induced ferroptosis via RAS-JNK", p38 signaling in HL-60, Am. J. Cancer Res, pp.2019, 9[DOI]
- Zhang, H. Y., "Protective effects of dexazoxane on rat ferroptosis in doxorubicin-induced cardiomyopathy through regulating HMGB1", Front. Cardiovasc. Med, 8, pp.685434~ (2021)
- Qian, Z. M., "Lipopolysaccharides upregulate hepcidin in neuron via microglia and the IL-6", STAT3 signaling pathway, 2014, pp.50, 811~820